	A Randomised Controlled Trial Comparing the Effects of Personalised Diet and Physical Activity Intervention Versus Usual Care on Cardiometabolic Risk Factors in Adults with Inactive Inflammatory Bowel Disease. Nutrients Yap JM, Wall CL, Meredith-Jones K, Iosua E, Osborne H, Schultz M. PMID: 41829955 [PubMed - indexed for MEDLINE]
	Etrasimod Treatment Modulates Circulating and Lymph Node-Derived Lymphocytes in Crohn's Disease. Int J Mol Sci Nikolakis D, Pruijt MJ, Verhoeff J, de Voogd FAE, Teichert C, Ryan RD, Branquinho D, Crosby C, van de Sande MGH, Grootjans J, D'Haens GR. PMID: 41828664 [PubMed - indexed for MEDLINE]
	Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease. Int J Mol Sci Peterson AR, Eggenhuizen PJ, Gan PY, Keung C, Ooi J, Moore GT, Goldberg R. PMID: 41828431 [PubMed - indexed for MEDLINE]
	Serum Cytokine Profiles Associated with Inflammation and Tumor Progression in Crohn's Disease and Colorectal Cancer. Int J Mol Sci , Lorenc-Góra J, Muc-Wierzgo, , Kowalczyk P, Czuba ZP, Waniczek D. PMID: 41828384 [PubMed - indexed for MEDLINE]
	A Developmental Perspective on the Intestinal Microbiota in Crohn's Disease. Int J Mol Sci Imbrizi M, Magro DO, Santos A, Assalin HB, Guadagnini D, Saad MJA, Coy CSR. PMID: 41828373 [PubMed - indexed for MEDLINE]
	Rice-Fried and Sun-Dried Ginseng: A Comparative Study of Chemical Composition and Protective Effects Against Ulcerative Colitis. Int J Mol Sci Chu Q, Zhang Y, Li J, Sun J, Liu G, Gao H. PMID: 41828369 [PubMed - indexed for MEDLINE]
	Correction: From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis. Z Gastroenterol Schnoy E, Dignass A, Gaskins M, Kucharzik T. PMID: 41825477 [PubMed - in process]
	A methodological concern regarding small-sample propensity score matching and overfitting in the study of postoperative biologic strategies for Crohn's disease. Inflamm Bowel Dis Xia J, Zhang Y. PMID: 41824762 [PubMed - as supplied by publisher]
	Short- and Long-Term Outcomes of Mirikizumab for Ulcerative Colitis: A Real-World Multicenter Retrospective Cohort Study from the INSIGHT study. Digestion Sawada T, Yamamura T, Maeda K, Ishikawa E, Murate K, Miyake N, Matsuura R, Fujiyoshi T, Uchida G, Suzuki H, Nishikawa T, Kuno T, Hattori S, Urata N, Ohashi A, Hasegawa I, Nakamura M, Kawashima H. PMID: 41824618 [PubMed - as supplied by publisher]
	Anxiety and depression in newly diagnosed patients with inflammatory bowel disease (the IBSEN III study) compared with the general population in Norway. J Crohns Colitis Johansen I, Hagen MC, Løkkeberg ST, Aabrekk TB, Asak Ø, Bengtson MB, Boyar R, Detlie TE, Frigstad SO, Aass Holten KI, Hovde Ø, Hüppert-Hauss G, Lund C, Medhus AW, Olsen BC, Strande V, Torp R, Vatn S, Høivik ML, Kristensen V, Jelsness-Jørgensen LP, Opheim R. PMID: 41824394 [PubMed - indexed for MEDLINE]
	Gut microbial metabolites in inflammatory bowel disease: immunological mechanisms regulating Treg/Th17 balance and therapeutic potential. Front Immunol Chen H, Yu S, Zhang M, Tian B, Yang L, Lu J. PMID: 41822494 [PubMed - indexed for MEDLINE]
	The IBD-disk accurately assesses disability and psychological burden at IBD diagnosis and predicts adverse outcomes in both UC and Crohn's disease during the first year of treatment: a prospective observational cohort study. Front Gastroenterol (Lausanne) Rimmer P, Stoica V, Ibrahim M, Javed A, Hazel K, Owusu M, Regan-Komito D, Cooney R, Iqbal AJ, Chapple I, Harvey P, Iqbal TH. PMID: 41822284 [PubMed]
	Case Report: Rapid resolution of fever after initiation of third-line rescue treatment with upadacitinib for acute severe ulcerative colitis in two young men. Front Gastroenterol (Lausanne) Pinzaru D, Kreysing M, Lesmeister T, Schwandner M, Michl P, Gauss A. PMID: 41822282 [PubMed]
	Curcumin-QingDai combination for patients with active Crohn's disease: a retrospective, real-world multicenter cohort study. Front Gastroenterol (Lausanne) Salomon N, Marom M, Odeh S, Molnar M, Shitrit AB, Nayshool O, Ungar B, Ben-Horin S, Rainis T. PMID: 41822273 [PubMed]
	Gastrointestinal endoscopy for intestinal dysplasia and neoplasia detection and management in Crohn's disease: when and how? Front Gastroenterol (Lausanne) Pessarelli T, Piagnani A, Tontini GE, Bergna IMB, Amato A. PMID: 41822261 [PubMed]
	Correction: Biomarkers of Probiotic Therapy in Ulcerative Colitis: A Systematic Review of Mechanisms Underlying Remission. Cureus Farhad ME, Belal I, Baana M, Childs C, Al-Rufayie M. PMID: 41822248 [PubMed]
	Clinical Efficacy of Early and Late Vedolizumab or Infliximab Interventions in Moderate Ulcerative Colitis: A Multicenter, Retrospective Cohort Study. Gastroenterology Res Meng RP, Zhang J, Wei HQ, Liao XP, Liu E, Lin H, Huang BB, Lyu L, Wei YL, Zhou JY, Xie X. PMID: 41822180 [PubMed]
	Clinical and biochemical factors associated with moderate-to-severe ulcerative colitis: a retrospective case-control study. BMC Gastroenterol Zhang C, Huang X. PMID: 41820894 [PubMed - as supplied by publisher]
	Integrated Assessment of Intestinal Barrier Function and Microscopic Inflammation Using Confocal Laser Endomicroscopy for Relapse Prediction in Ulcerative Colitis. United European Gastroenterol J Minea H, Sfarti C, Chiriac S, Sîngeap AM, Danciu M, Blaj M, Cimpoesu CD, Iosep D, Muzic, Balan G, Zenovia S, Avram R, Huiban L, Juncu S, Trifan A. PMID: 41820246 [PubMed - indexed for MEDLINE]
	Correlation between patient-determined inflammatory bowel disease severity and the inflammatory bowel disease severity index. N Z Med J McCombie AM, Siegel CA, Hanauer SB, McAuliffe T, Salwen-Deremer J, Hughes H, Gearry R. PMID: 41818761 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 57053

Page 1 of 2853



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy